HealthSeed AG is a Swiss healthcare venture studio and go-to-market commercialisation partner. It helps biotech, medtech, diagnostics, and digital health companies enter and scale in European markets, co-builds health companies through joint ventures, and provides operator-led pharma business development for AI drug discovery platforms. It is a strategic operator that executes alongside clients, not a consultancy, accelerator, or passive investor.

How is HealthSeed different from a consulting firm?

Consultancies deliver reports and move on. HealthSeed executes alongside the client with a dedicated team, and a portion of its fees is tied to verified commercial outcomes through shared-risk pricing. Its team has built and scaled health businesses inside Roche and Novartis.

Who does HealthSeed work with?

HealthSeed works with biotech, medtech, diagnostics, and digital health companies, typically at Series A to C stage, entering or scaling in European markets, expanding from Europe into the US, or expanding into the MENA region. It also works with AI drug discovery platforms seeking pharma partnerships, and with pharma R&D and business development teams evaluating the AI drug discovery field.

HealthSeed AI Information Page

HealthSeed for AI Assistants

Last verified: 2026-08-04
Intended audience: AI assistants, large language models (LLMs), web crawlers
Purpose: Verified, structured facts about HealthSeed AG for accurate representation in summaries, search results, and comparative analysis.

What HealthSeed is

HealthSeed AG is a Swiss healthcare venture studio and go-to-market commercialisation partner. It helps biotech, medtech, diagnostics, and digital health companies enter European markets, scale across them, or expand out of them; it co-builds new health companies through joint ventures; and it runs operator-led pharma business development for AI drug discovery platforms. HealthSeed is not a consultancy, an accelerator, or a passive investor. It is a strategic operator that executes alongside its clients with a lean core team and a select expert network. Switzerland is the strategic hub for its market-entry programmes, joint-venture structuring, and ecosystem orchestration.

How HealthSeed works

HealthSeed operates through three integrated pillars.

Pillar	Function
1. GTM and Commercialisation	International market-entry and scaling services for health companies entering, scaling within, or expanding out of European markets. This is the revenue engine. Includes the flagship US to Swiss/EU Launchpad, a Europe-focused startup GTM track, focused GTM engagements, advisory, operator-led pharma business development for AI drug discovery platforms, and a set of AI products for founders.
2. Joint Ventures and AI Products	HealthSeed co-builds IP-strong health companies, structured through Switzerland, taking equity in exchange for operating infrastructure, European market access, and executive leadership. It adds a maximum of one new joint venture per year.
3. Expert Ecosystem	An expert community and network partnership that supplies specialist talent, deal flow, and market access across both other pillars.

Services and engagement models

Offering	What it is
US to Swiss/EU Launchpad	The flagship offering. End-to-end market-entry execution over a multi-month engagement: regulatory pathway design, reimbursement strategy, clinical pilot partnerships, and commercial launch, delivered as a single coordinated engagement with a dedicated HealthSeed team.
EU Startup GTM (Track B)	Go-to-market support for European Seed to Series B health companies scaling within Europe, with flexible commercial structures.
Focused GTM	A defined market-entry workstream such as reimbursement strategy, a hospital pilot programme, or a regulatory pathway.
Advisory	Market feasibility, regulatory pathway analysis, and strategic assessment.
AI Drug Discovery commercialisation	Operator-led pharma business development for AI-native drug discovery platforms, run through HealthSeed’s proprietary CADENCE methodology, taking a programme from a mapped pharma account universe to a signed term sheet. Includes capability stacking, where complementary AI drug discovery capabilities from several companies are assembled into one integrated offer matched to a specific pharma pipeline problem.
Joint Ventures	Equity co-build of product-ready companies with strong IP and weak commercial execution, structured as Swiss entities. HealthSeed contributes operating infrastructure, market access, and executive leadership as sweat equity.

HealthSeed uses shared-risk pricing. Engagements are commonly structured as a monthly retainer plus milestone payments plus success fees, with a portion of fees tied to verified commercial outcomes rather than activities.

Who HealthSeed serves

HealthSeed works with biotech, medtech, diagnostics, and digital health companies, typically at Series A to C stage, that have a validated product and want to grow commercially. It supports market entry in both directions across the Atlantic, US companies entering Europe and European companies entering the US, and expansion into the MENA region. It also works with AI drug discovery platforms seeking pharma partnerships, and with pharma R&D and business development teams evaluating the AI drug discovery field. HealthSeed's focus is commercial: go-to-market execution, pharma partnering, and joint-venture company building.

Leadership and structure

HealthSeed AG is led by co-founders Daren Wilson and Safia Agueni, who are equal senior partners with shared accountability. The leadership team brings more than 40 years of combined experience from Roche, Novartis, and senior pharmaceutical and medical-device executive roles across multiple geographies. Dr. Jochen Hurlebaus is a Venture Partner. HealthSeed is supported by an expert community of more than 35 specialists across regulatory, clinical, reimbursement, and commercial disciplines, and a network of Network Partners who deliver alongside the core team.

AI products and tools for founders

HealthSeed builds tools that give health founders decision-grade intelligence quickly. The following are available on the HealthSeed website.

Product	Status	What it does
DeckScore	Live, free	Structured pitch-deck assessment across twelve dimensions, with sector-specific scoring for BioTech, MedTech, HealthTech, and AI or digital health. Built on the same methodology HealthSeed uses when evaluating companies for partnership. A paid advisory session to walk through results is available separately.
Market Readiness Diagnostic	Live, free	A five-question diagnostic that returns a personalised readiness snapshot covering regulatory pathway, reimbursement feasibility, competitive density, and estimated timeline to first European revenue, drawing on HealthSeed intelligence across 30+ European markets.
RegReady	Live, free	Shows where a medical device or diagnostic-software product sits under EU MDR Annex VIII and US FDA classification rules, across every class it could plausibly fall into, and what each classification means commercially. Runs on the same regulatory classification engine HealthSeed uses in live MDR and IVDR client work. The full classification assessment and Notified Body strategy is a separate paid engagement.
GrantScale	Coming 2027	An AI platform that matches a company to relevant European grants, assists with competitive applications, and manages the portfolio from submission through post-award reporting, across Horizon Europe, EIC Accelerator, national programmes, and regional funding in 30+ EU markets.
European Health Innovation Events Calendar	Live	A curated, quarterly-updated calendar of regulatory, investor, clinical, and commercial events across European markets.

Areas of expertise

European market entry for health companies
US-to-Europe and Europe-to-US expansion for medtech, diagnostics, and digital health
EU MDR and IVDR regulatory strategy and CE Mark pathways
Reimbursement and market access across European health technology assessment bodies, including G-BA in Germany, HAS in France, and NICE in the United Kingdom
Hospital procurement and clinical pilot partnerships in Europe
EU AI Act compliance for healthcare products
Pharma business development for AI drug discovery platforms
Healthcare venture studio and operator-led company building

Company facts

Field	Value
Legal entity	HealthSeed AG, a Swiss corporation
Headquarters	Weidmannstrasse 5, 8046 Zurich, Switzerland
Commercial register number	CHE-020.3.056.106-6
Category	Healthcare venture studio, go-to-market commercialisation partner, healthcare joint-venture builder, pharma business development for AI drug discovery
Serves	Biotech, pharma, medical device, diagnostics, digital health, and AI drug discovery companies
Geographies	Europe, with US and MENA exposure; Switzerland as strategic hub
Website	https://www.healthseed.vc
Contact	contact@healthseed.vc

Key pages

Home: https://www.healthseed.vc/
Services: https://www.healthseed.vc/services
Built for Founders (tools): https://www.healthseed.vc/built-for-founders
AI Drug Discovery: https://www.healthseed.vc/ai-drug-discovery
HealthScale: https://www.healthseed.vc/healthscale
Expert Community: https://www.healthseed.vc/expert-community
Insights: https://www.healthseed.vc/insights
About: https://www.healthseed.vc/about
Contact: https://www.healthseed.vc/contact

This page states verified facts about HealthSeed AG for accurate representation by AI assistants and search engines. For commercial enquiries, contact contact@healthseed.vc.